HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Anti-analgesic and anti-amnesic effect of complement C3a.

Abstract
In the present study, we found that complement C3a exerted central effects after intracerebroventricular administration in mice. At doses of 3 and 10 pmol/mouse, the peptide showed an antagonistic effect on analgesia induced by morphine and U-50488H, known to be mu- and kappa-opioid receptor agonists, respectively. Moreover, complement C3a improved scopolamine- and ischemia-induced amnesia at a dose of 10 pmol/mouse. Anti-analgesia was not observed by C3a des-Arg at 10 pmol/mouse. The present findings suggest that complement C3a may act as a peptide with anti-opioid activity in the central nervous system.
AuthorsY Jinsmaa, M Takahashi, M Takahashi, M Yoshikawa
JournalLife sciences (Life Sci) Vol. 67 Issue 17 Pg. 2137-43 (Sep 15 2000) ISSN: 0024-3205 [Print] ENGLAND
PMID11057763 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics
  • Oligopeptides
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Morphine
  • Complement C3a
  • deltakephalin
Topics
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer (administration & dosage, antagonists & inhibitors, pharmacology)
  • Analgesics (administration & dosage, pharmacology)
  • Animals
  • Avoidance Learning (drug effects)
  • Cerebral Ventricles (drug effects, physiology)
  • Complement C3a (administration & dosage, pharmacology)
  • Dose-Response Relationship, Drug
  • Electroshock
  • Humans
  • Injections, Intraventricular
  • Ischemia (physiopathology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Morphine (administration & dosage, antagonists & inhibitors, pharmacology)
  • Oligopeptides (administration & dosage, pharmacology)
  • Pain (physiopathology)
  • Receptors, Opioid, delta (agonists)
  • Receptors, Opioid, kappa (agonists)
  • Receptors, Opioid, mu (agonists)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: